Nanoparticle-Based Delivery Systems for Targeting Molecular Proteins in Cancer Progression: Recent Advances, Challenges, and Future Perspectives

The review should discuss how nanoparticle-based drug delivery systems improve the targeting of oncogenic proteins, enhance drug bioavailability, reduce systemic toxicity, and enable precision oncology. It should also critically evaluate recent advances in ligand-directed nanoparticles, biomimetic nanocarriers, stimuli-responsive systems, and translational challenges.